A Biomarker Study of Tivozanib in Subjects With Advanced Renal Cell Carcinoma
Clinical trial NCT01297244 · COMPLETED
Trial details
- NCT number
- NCT01297244
- Sponsor
- AVEO Pharmaceuticals, Inc.
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2011-01-01
- Primary completion
- 2012-10-01
- Enrollment
- 105
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.